10.21037/jgo-21-916 63 HuangS.WangY.XieS.LaiY.MoC.ZengT.et al (2022a)
Biogerontology 27 , 100 (2026)
Epitalon increased IL-2 expression in targeted brain regions, implying that it may recalibrate immune tone from the top down [52]
But theyre basically saying, Look, we believe that peptides will be saved. In fact, pharmacists have pushed back against a regulatory process they describe as murky and unfair
Neither peptide "wins" outright because they act on different phases of the repair cascade rather than competing: for localised tendon and ligament models, BPC-157 has the stronger preclinical evidence (early-phase angiogenesis and growth-factor signalling)
Personally I would not worry to much about this effect, given that CPs have other very attractive effects that can promote beard growth